BRPI0721883A2 - Composição farmacêutica contendo antagonista de canal de cálcio de dihidropiridina e processo para a preparação da mesma - Google Patents

Composição farmacêutica contendo antagonista de canal de cálcio de dihidropiridina e processo para a preparação da mesma

Info

Publication number
BRPI0721883A2
BRPI0721883A2 BRPI0721883-4A2A BRPI0721883A BRPI0721883A2 BR PI0721883 A2 BRPI0721883 A2 BR PI0721883A2 BR PI0721883 A BRPI0721883 A BR PI0721883A BR PI0721883 A2 BRPI0721883 A2 BR PI0721883A2
Authority
BR
Brazil
Prior art keywords
preparing
pharmaceutical composition
composition containing
calcium channel
channel antagonist
Prior art date
Application number
BRPI0721883-4A2A
Other languages
English (en)
Inventor
Evangelos Karavas
Efthimios Koutris
Ioanna Koutri
Eleni Stathaki
Original Assignee
Pharmathen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39223083&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0721883(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmathen Sa filed Critical Pharmathen Sa
Publication of BRPI0721883A2 publication Critical patent/BRPI0721883A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
BRPI0721883-4A2A 2007-07-23 2007-07-23 Composição farmacêutica contendo antagonista de canal de cálcio de dihidropiridina e processo para a preparação da mesma BRPI0721883A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2007/006517 WO2009012791A1 (en) 2007-07-23 2007-07-23 Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof

Publications (1)

Publication Number Publication Date
BRPI0721883A2 true BRPI0721883A2 (pt) 2014-02-18

Family

ID=39223083

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0721883-4A2A BRPI0721883A2 (pt) 2007-07-23 2007-07-23 Composição farmacêutica contendo antagonista de canal de cálcio de dihidropiridina e processo para a preparação da mesma
BRPI0814666A BRPI0814666A2 (pt) 2007-07-23 2008-07-23 composição farmacêutica para a administração oral, uso de uma formulação. processo para a preparação de uma forma de dosagem sólida, e, forma de dosagem sólida

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0814666A BRPI0814666A2 (pt) 2007-07-23 2008-07-23 composição farmacêutica para a administração oral, uso de uma formulação. processo para a preparação de uma forma de dosagem sólida, e, forma de dosagem sólida

Country Status (20)

Country Link
EP (2) EP2180883B1 (pt)
JP (2) JP5769963B2 (pt)
KR (2) KR101632079B1 (pt)
CN (3) CN101784260A (pt)
AU (2) AU2007356942B2 (pt)
BR (2) BRPI0721883A2 (pt)
CA (2) CA2691752C (pt)
CO (1) CO6290639A2 (pt)
CR (1) CR11285A (pt)
EA (2) EA021645B1 (pt)
EC (1) ECSP109984A (pt)
ES (2) ES2622495T3 (pt)
MA (1) MA31684B1 (pt)
MX (2) MX2010000856A (pt)
MY (1) MY153857A (pt)
NZ (2) NZ582648A (pt)
TN (2) TN2010000011A1 (pt)
UA (2) UA97161C2 (pt)
WO (2) WO2009012791A1 (pt)
ZA (2) ZA201000586B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
CN101808994B (zh) 2007-07-17 2013-05-15 普莱希科公司 用于激酶调节的化合物和方法以及其适应症
EA021645B1 (ru) * 2007-07-23 2015-08-31 Фарматен С.А. Твердая дозированная форма в виде таблетки и способ её приготовления
KR101739994B1 (ko) 2009-04-03 2017-05-25 에프. 호프만-라 로슈 아게 프로판-１-술폰산 ｛３-［５-（４-클로로-페닐）-１Ｈ-피롤로［２，３-ｂ］피리딘-３-카르보닐］-２，４-디플루오로-페닐｝-아미드 조성물 및 그의 용도
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
KR20120102669A (ko) 2009-11-06 2012-09-18 플렉시콘, 인코퍼레이티드 키나제 조정을 위한 화합물 및 방법, 및 이를 위한 적응증
EP2672967B1 (en) 2011-02-07 2018-10-17 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
TWI558702B (zh) 2011-02-21 2016-11-21 普雷辛肯公司 醫藥活性物質的固態形式
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
JP2015537029A (ja) 2012-11-14 2015-12-24 ダブリュー・アール・グレース・アンド・カンパニー−コーンＷ Ｒ Ｇｒａｃｅ ＆ Ｃｏ−Ｃｏｎｎ 生物学的に活性な物質及び不規則性無機酸化物を含有する組成物
GR1008554B (el) * 2014-06-12 2015-09-03 ΦΑΡΜΑΤΕΝ ΑΝΩΝΥΜΟΣ ΒΙΟΜΗΧΑΝΙΚΗ ΚΑΙ ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΙΑΤΡΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ με δ.τ. ΦΑΡΜΑΤΕΝ, Φαρμακευτικο σκευασμα περιεχον εναν αντιμυκητιασικο παραγοντα τριaζολης και μεθοδος για την παρασκευη αυτου
CN104069500A (zh) * 2014-06-20 2014-10-01 湖南天地恒一制药有限公司 一种包含乐卡地平的药物组合物
CN105168165B (zh) * 2015-08-28 2018-06-26 江苏福邦药业有限公司 一种盐酸乐卡地平片及其制备方法
WO2018004379A1 (ru) * 2016-07-01 2018-01-04 Общество С Ограниченной Ответственностью "Гиостин" Средство в виде капсулы для лечения заболеваний суставов
CN114533686B (zh) * 2022-02-15 2023-10-20 湖南普道医药技术有限公司 一种二氢吡啶类药物的口服固体制剂及其制备方法
KR20240040407A (ko) * 2022-09-21 2024-03-28 주식회사 종근당 사쿠비트릴ㆍ발사르탄 칼슘염을 포함하는 약제학적 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
US5209933A (en) * 1990-01-10 1993-05-11 Syntex (U.S.A.) Inc. Long acting calcium channel blocker composition
GB9025251D0 (en) * 1990-11-20 1991-01-02 Solomon Montague C Nifedipine dosage forms
BR9903490A (pt) * 1998-12-15 2000-09-26 Oscar Gold Processo para a preparação de composições farmacêuticas de liberação programada contendo nimodipine, que permitem a liberação gradual e a manuntenção da ação terapeutica
DE19944803A1 (de) * 1999-09-20 2001-03-29 Bayer Ag Kombination von Dihydropyridinverbindungen und HMG-CoA-Reduktase-Inhibitoren und ihre Verwendung in Arzneimitteln
US20040185097A1 (en) * 2003-01-31 2004-09-23 Glenmark Pharmaceuticals Ltd. Controlled release modifying complex and pharmaceutical compositions thereof
ZA200605290B (en) * 2003-12-01 2007-10-31 Lifecycle Pharma As Pharmaceutical compositions comprising lercanidipine
ES2281313T3 (es) * 2003-12-01 2020-07-24 Recordati Ireland Ltd Composiciones farmacéuticas que comprenden lercanidipino
WO2008025535A1 (en) * 2006-08-30 2008-03-06 Jagotec Ag Controlled release oral dosage formulations comprising a core and one or more barrier layers
EP2101771A2 (en) * 2006-12-06 2009-09-23 Torrent Pharmaceuticals Ltd Stable lercanidipine formulation
EA021645B1 (ru) * 2007-07-23 2015-08-31 Фарматен С.А. Твердая дозированная форма в виде таблетки и способ её приготовления

Also Published As

Publication number Publication date
CN101801347A (zh) 2010-08-11
NZ582648A (en) 2012-06-29
EA021645B1 (ru) 2015-08-31
CA2691752A1 (en) 2009-01-29
TN2010000011A1 (en) 2011-09-26
ZA201001176B (en) 2010-11-24
EP2180883A1 (en) 2010-05-05
WO2009012791A1 (en) 2009-01-29
NZ582690A (en) 2011-12-22
BRPI0814666A2 (pt) 2017-05-09
AU2008280106B9 (en) 2014-08-07
EP2170295A1 (en) 2010-04-07
CN101784260A (zh) 2010-07-21
MA31684B1 (fr) 2010-09-01
AU2007356942A1 (en) 2009-01-29
KR101632079B1 (ko) 2016-06-20
CA2693233A1 (en) 2009-01-29
CR11285A (es) 2010-04-27
MX2010000801A (es) 2010-07-05
MX2010000856A (es) 2010-04-30
JP5769963B2 (ja) 2015-08-26
TN2010000022A1 (en) 2011-09-26
CA2691752C (en) 2016-01-26
ZA201000586B (en) 2011-03-30
UA97161C2 (ru) 2012-01-10
AU2008280106A1 (en) 2009-01-29
EA019614B1 (ru) 2014-05-30
AU2008280106B2 (en) 2014-03-20
KR20100045456A (ko) 2010-05-03
ES2622495T3 (es) 2017-07-06
CO6290639A2 (es) 2011-06-20
ES2537063T3 (es) 2015-06-02
JP2010534220A (ja) 2010-11-04
MY153857A (en) 2015-03-31
WO2009013306A1 (en) 2009-01-29
UA99136C2 (ru) 2012-07-25
KR101512404B1 (ko) 2015-04-21
KR20100047848A (ko) 2010-05-10
ECSP109984A (es) 2010-04-30
EA201070160A1 (ru) 2010-06-30
AU2007356942B2 (en) 2011-12-15
AU2008280106A2 (en) 2010-02-25
EP2170295B1 (en) 2015-04-22
EP2180883B1 (en) 2017-01-11
EA201000220A1 (ru) 2010-08-30
CN103976968A (zh) 2014-08-13
JP2010534211A (ja) 2010-11-04

Similar Documents

Publication Publication Date Title
BRPI0721883A2 (pt) Composição farmacêutica contendo antagonista de canal de cálcio de dihidropiridina e processo para a preparação da mesma
BRPI0717149A2 (pt) Composição oral contendo redes de gel e processo para o preparo da mesma
BRPI0818533A2 (pt) composto, composição farmacêutica, e, processo para a preparação de um composto
BRPI0924136A2 (pt) composição farmacêutica sólida compreendendo amlodipina e losartan e processo para a produção da mesma
BRPI0905717A2 (pt) Composição farmacêutica, processo para preparar uma composição farmacêutica e forma de dosagem farmacêutica
BRPI0818680A2 (pt) composição farmacêutica, preparação farmacêutica, e método para preparar um forma de dosagem oral farmacêutica
BRPI0909691A8 (pt) composto, método para preparar um composto, e, composição farmacêutica
BRPI0810763A2 (pt) Composição aglutinante betuminosa e processo para preparação da mesma
BRPI0907598A2 (pt) Processo para o preparo de formulações de dabigatrana administradas por via oral
BRPI0815387A2 (pt) composição farmacêutica, método para fazer uma composição farmacêutica e método de tratar uma condição
BRPI0816991A2 (pt) Formulação, processo para preparar a mesma, e, usos de uma composição antimicrobiana e de uma formulação
BRPI0607423A2 (pt) forma microcristalina de um composto, processo para a preparação da mesma, uso de uma forma microcristalina, composição farmacêutica e processo para a preparação da mesma, e, produto
BRPI0808034A2 (pt) Método para produzir hidrocloreto de prasugrel, hidrocloreto de prasugrel, composição farmacêutica, e, uso de um hidrocloreto de prasugrel.
BRPI0811996A2 (pt) Composição amaciante para tecido, e, método para amaciar um tecido
IL187330A0 (en) A method of marking composition for oral administration
BRPI0905388A2 (pt) "composição farmacêutica; compostos e métodos de tratamento de infecção por arenavirus"
BRPI0821761A2 (pt) Composições de comprimidos de desintegração oral de temazepam
BRPI1007161A2 (pt) composição farmacêutica oral, e processo para preparar uma composição
BRPI0818430A2 (pt) Composição antiperspirante sólida e método para a produção da mesma
BRPI0814300A2 (pt) Composto, composição farmacêutica, e, método para tratar uma infecção viral
BRPI0810169A2 (pt) Processo e máquina para abaixamento de um trilho
BRPI0910545A2 (pt) processo contínuo para fazer composições farmacêuticas
BRPI0814163A2 (pt) Processo para a preparação de compostos, forma cristalina, e, composição farmacêutica
BRPI0817721A2 (pt) Composto, composição farmacêutica, método de tratamento, e, processo para preparação de um composto
BRPI0905790A2 (pt) 'micropartícula, método para a fabricação de micropartícula e preparação farmacêutica

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Technical examination (opinion): publication of technical examination (opinion)
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 12A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2524 DE 21-05-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.